| Zoetis is a holding company. Through its subsidiaries, Co. develops, manufactures and commercializes medicines, vaccines, diagnostic products and services, biodevices, genetic tests and animal health technology. Co.'s product categories include: vaccines, which are biological preparations that help prevent diseases of the respiratory, gastrointestinal and reproductive tracts or induce a specific immune response; and parasiticides, which are products that prevent or eliminate parasites. Co.'s other non-pharmaceutical product categories include nutritionals and agribusiness, as well as products and services in biodevices, genetic tests and precision animal health. We show 43 historical shares outstanding datapoints in our coverage of ZTS's shares outstanding history.
Understanding the changing numbers of ZTS shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ZTS versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ZTS by allowing them to research ZTS shares outstanding history
as well as any other stock in our coverage universe.